Terumo Corp. (TRUMY)
15.84
-0.15
(-0.94%)
USD |
OTCM |
Aug 28, 16:00
Terumo Cash from Operations (Quarterly) : 467.38M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 467.38M |
| March 31, 2026 | 565.25M |
| December 31, 2025 | 258.29M |
| September 30, 2025 | 477.30M |
| June 30, 2025 | 225.77M |
| March 31, 2025 | 427.85M |
| December 31, 2024 | 301.71M |
| September 30, 2024 | 420.32M |
| June 30, 2024 | 229.09M |
| March 31, 2024 | 383.02M |
| December 31, 2023 | 249.84M |
| September 30, 2023 | 294.53M |
| June 30, 2023 | 83.11M |
| March 31, 2023 | 329.24M |
| December 31, 2022 | 93.00M |
| September 30, 2022 | 269.04M |
| June 30, 2022 | 179.92M |
| March 31, 2022 | 376.70M |
| December 31, 2021 | 279.07M |
| September 30, 2021 | 334.20M |
| June 30, 2021 | 273.35M |
| March 31, 2021 | 463.86M |
| December 31, 2020 | 303.08M |
| September 30, 2020 | 227.21M |
| June 30, 2020 | 161.91M |
| Date | Value |
|---|---|
| March 31, 2020 | 397.83M |
| December 31, 2019 | 216.70M |
| September 30, 2019 | 285.14M |
| June 30, 2019 | 174.86M |
| March 31, 2019 | 330.80M |
| December 31, 2018 | 158.33M |
| September 30, 2018 | 240.68M |
| June 30, 2018 | 114.07M |
| March 31, 2018 | 373.23M |
| December 31, 2017 | 231.81M |
| September 30, 2017 | 287.15M |
| June 30, 2017 | 134.98M |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Mani, Inc. | -- |
| Nipro Corp. | -- |
| HOYA Corp. | 456.63M |
| Nakanishi, Inc. | -- |
| Abbott Laboratories | 2.488B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -177.42M |
| Cash from Financing (Quarterly) | -101.60M |
| Free Cash Flow | 1.116B |
| Free Cash Flow Per Share (Quarterly) | 0.2367 |
| Free Cash Flow to Equity (Quarterly) | 638.88M |
| Free Cash Flow to Firm (Quarterly) | 356.50M |
| Free Cash Flow Yield | 4.78% |